| Table of Contents
6 Figures and Tables
10 Executive Summary
12 Key Findings and Implications
15 Transfection Dashboard
19 Transfection Market Opportunity Matrix
21 Survey Methodology
22 Survey Invitation Text
24 Respondent Demographics
37 Frequency of Performance of Life Science Techniques
42 Frequency of Transfection of Mammalian Cells or Cell Lines
54 Reaction Throughput and Market Growth Rates
60 Respondent’s Stated Price Per Reaction
63 Total Market Size, Market Segment Sizes and Total Market Growth Rate
66 Market Shares for Products for Chemically-Mediated Transfection
of Mammalian Cells or Cell Lines
70 Market Shares for Products for Lipid-Mediated Transfection of
Mammalian Cells or Cell Lines
74 Market Shares for Products for Instrument-Mediated Transfection
of Mammalian Cells or Cell Lines
78 Market Shares for Products for Virus-Mediated Transfection of
Mammalian Cells or Cell Lines
83 Customer Satisfaction And Interest In Switching Suppliers
90 Product Features That Influence Purchasing Decisions
94 Primary and Secondary Downstream Applications
114 Desired Changes to Transfection Products
122 Survey Questionnaire
Figures and Tables
26 Figure 1: Respondent’s Place of Employment
28 Figure 2: Respondent’s Country/Region
30 Figure 3: Respondent’s Job Title
32 Figure 4: Respondent’s Areas of Expertise/Specialization
36 Figure 5: Number of Employees in Respondent’s Laboratories
39 Figure 6: Percentage of Respondents Performing Various Life
Science Techniques at Least a Few Times per Year
44 Figure 7: Percentage of Respondents Transfecting Mammalian
Cells or Cell Lines
44 Figure 8: Percentage of Respondents Performing Transfection of
Mammalian Cells or Cell Lines at Least a Few Times Per Year
47 Figure 9: Percentage of Respondents Performing Chemically-Mediated
Transfection of Mammalian Cells or Cell Lines
48 Figure 10: Percentage of Respondents Performing Lipid-Mediated
Transfection of Mammalian Cells or Cell Lines
49 Figure 11: Percentage of Respondents Performing Instrument-Mediated
Transfection of Mammalian Cells or Cell Lines
50 Figure 12: Percentage of Respondents Performing Virus-Mediated
Transfection of Mammalian Cells or Cell Lines
67 Figure 13: Respondent’s Primary Supplier for Chemically-Mediated
Transfection of Mammalian Cells or Cell Lines
71 Figure 14: Respondent’s Primary Supplier for Lipid-Mediated
Transfection of Mammalian Cells or Cell Lines
75 Figure 15: Respondent’s Primary Supplier for Instrument-Mediated
Transfection of Mammalian Cells or Cell Lines
79 Figure 16: Respondent’s Primary Supplier for Virus-Mediated
Transfection of Mammalian Cells or Cell Lines
88 Figure 17: Percentage of Respondents That Have Switched Suppliers
in the Last Six Months
89 Figure 18: Percentage of Respondents That Have Switched from the
following Suppliers to a Different Supplier in the Last Six Months
92 Figure 19: Most Important Features of Transfection Products
96 Figure 20: Respondent’s Primary Application for Mammalian Cells or Cell
Lines After Chemically-Mediated Transfection
98 Figure 21: Respondent’s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Chemically-Mediated
Transfection
101 Figure 22: Respondent’s Primary Application for Mammalian Cells or
Cell Lines After Lipid-Mediated Transfection
103 Figure 23: Respondent’s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Lipid-Mediated Transfection
106 Figure 24: Respondent’s Primary Applications for Mammalian Cells
or Cell Lines After Instrument-Mediated Transfection
108 Figure 25: Respondent’s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Instrument-Mediated
Transfection
111 Figure 26: Respondent’s Primary Applications for Mammalian Cells or
Cell Lines After Virus-Mediated Transfection
113 Figure 27: Respondent’s Primary and Secondary Applications for
Mammalian Cells or Cell Lines After Instrument-Mediated
Transfection
|
